Hu B, Reagan PM, Sehn LH, et al. Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study. Blood Adv. 2025;9(10):2489-2499.
Hu B, Reagan PM, Sehn LH, et al. Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study. Blood Adv. 2025;9(10):2489-2499. // Blood Advances. – URL: https://www.sciencedirect.com/science/article/pii/S2473952926006634?dgcid=rss_sd_all
Hu B, Reagan PM, Sehn LH, et al. Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study. Blood Adv. 2025;9(10):2489-2499. Blood Advances. https://www.sciencedirect.com/science/article/pii/S2473952926006634?dgcid=rss_sd_all
“Hu B, Reagan PM, Sehn LH, et al. Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study. Blood Adv. 2025;9(10):2489-2499.” Blood Advances.
@article{article38496,
title = {Hu B, Reagan PM, Sehn LH, et al. Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study. Blood Adv. 2025;9(10):2489-2499.},
journal = {Blood Advances},
url = {https://www.sciencedirect.com/science/article/pii/S2473952926006634?dgcid=rss_sd_all}
}